Recombinant GTF2F2 antibody

Catalog No. ABIN7828224

The Rabbit Monoclonal anti-GTF2F2 antibody (Clone A780) (ABIN7828224) specifically detects GTF2F2 in WB, IP and FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant GTF2F2 antibody (ABIN7828224)

Target: GTF2F2 (General Transcription Factor IIF, Polypeptide 2, 30kDa (GTF2F2))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This GTF2F2 antibody is un-conjugated

Application: Western Blotting (WB), Immunoprecipitation (IP), Flow Cytometry (FACS)

Clone: A780

Product Details anti-GTF2F2 Antibody

Purpose: Recombinant TFIIF beta Monoclonal Antibody

Purification: Protein A purified

Isotype: IgG, kappa

Application Details

Application Notes: WB 1:1000-1:2000,FCM 1:100,IP 1:50-1:100

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Expiry Date: 12 months

Target Details for GTF2F2

Target: GTF2F2 (General Transcription Factor IIF, Polypeptide 2, 30kDa (GTF2F2))

Alternative Name: TFIIF beta

Background: RAP,BTF,TF2F,GTF2F,GTF2F2,BTF4,RAP30,TF2F2,TFIIF,TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaborationwith TFIIB. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

Molecular Weight:

Calculated MW: 28 kDa

Observed MW: 30 kDa The actual band is not consistent with the expectation.

UniProt: P13984

Pathways: SARS-CoV-2 Protein Interactome